Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis-Reference-Cited by-同舟云学术

Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis

Published:2022-01 Issue: Volume:57 Page:103366
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Yik Jackie T.,Becquart Pierre,Gill Jasmine,Petkau John,Traboulsee Anthony,Carruthers Robert,Kolind Shannon H.,Devonshire Virginia,Sayao Ana-Luiza,Schabas Alice,Tam Roger,Moore G.R. Wayne,Li David K.B.,Stukas Sophie,Wellington Cheryl,Quandt Jacqueline A.,Vavasour Irene M.,Laule Cornelia

Funder

Multiple Sclerosis Society of Canada

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference86 articles.

1. Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis;Adams;J. Neurol. Sci.,1989

2. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis;Allen;J. Neurol. Sci.,1979

3. Serum neurofilament light chain withstands delayed freezing and repeated thawing;Altmann;Sci. Rep.,2020

4. Adult age differences in subcortical myelin content are consistent with protracted myelination and unrelated to diffusion tensor imaging indices;Arshad;NeuroImage,2016

5. Diffusion tensor MRI as a biomarker in axonal and myelin damage;Aung;Imaging Med.,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diffusion basis spectrum imaging and diffusion tensor imaging predict persistent black hole formation in multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-04

2. Serum neurofilament light chain predicts spinal cord atrophy in neuromyelitis optica spectrum disorder;Journal of Neuroimmunology;2023-11

3. Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study;Neurology and Therapy;2023-10-10

4. Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment;Neurology and Therapy;2023-09-08

5. NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis;Multiple Sclerosis and Related Disorders;2023-09